By expenditures
| Name | Title | Type |
|---|---|---|
| Patrick Vrba | Controller | Auditee |
| Greg Peterson | Partner | Auditee |
| Chad Lassen | Principal | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 381992 | 2025 | 2026-01-15 | CLIFTONLARSONALLEN LLP | $212.40M |
| 338457 | 2024 | 2025-01-16 | Cliftonlarsonallen LLP | $179.92M |
| 307792 | 2023 | 2024-05-31 | Cliftonlarsonallen LLP | $219.27M |
| 33279 | 2022 | 2023-03-26 | Weaver and Tidwell LLP | $225.55M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 381992 | 2025 | 2026-01-15 | 1169151 | 2025-002 | Material Weakness | Yes | N |
| 381992 | 2025 | 2026-01-15 | 1169150 | 2025-002 | Material Weakness | Yes | N |
| 381992 | 2025 | 2026-01-15 | 1169149 | 2025-002 | Material Weakness | Yes | N |
| 381992 | 2025 | 2026-01-15 | 1169148 | 2025-002 | Material Weakness | Yes | N |
| 381992 | 2025 | 2026-01-15 | 1169147 | 2025-001 | Material Weakness | Yes | E |
| 381992 | 2025 | 2026-01-15 | 1169146 | 2025-001 | Material Weakness | Yes | E |
| 381992 | 2025 | 2026-01-15 | 1169145 | 2025-001 | Material Weakness | Yes | E |
| 381992 | 2025 | 2026-01-15 | 1169144 | 2025-001 | Material Weakness | Yes | E |
| 307792 | 2023 | 2024-05-31 | 975716 | 2023-002 | Significant Deficiency | - | E |
| 307792 | 2023 | 2024-05-31 | 975715 | 2023-001 | Significant Deficiency | - | N |
| 307792 | 2023 | 2024-05-31 | 975714 | 2023-001 | Significant Deficiency | - | N |
| 307792 | 2023 | 2024-05-31 | 975713 | 2023-001 | Significant Deficiency | - | N |
| 307792 | 2023 | 2024-05-31 | 975712 | 2023-001 | Significant Deficiency | - | N |
| 307792 | 2023 | 2024-05-31 | 399274 | 2023-002 | Significant Deficiency | - | E |
| 307792 | 2023 | 2024-05-31 | 399273 | 2023-001 | Significant Deficiency | - | N |
| 307792 | 2023 | 2024-05-31 | 399272 | 2023-001 | Significant Deficiency | - | N |
| 307792 | 2023 | 2024-05-31 | 399271 | 2023-001 | Significant Deficiency | - | N |
| 307792 | 2023 | 2024-05-31 | 399270 | 2023-001 | Significant Deficiency | - | N |
| 33279 | 2022 | 2023-03-26 | 609289 | 2022-002 | Significant Deficiency | Yes | L |
| 33279 | 2022 | 2023-03-26 | 609288 | 2022-002 | Significant Deficiency | Yes | L |
| 33279 | 2022 | 2023-03-26 | 609287 | 2022-002 | Significant Deficiency | Yes | L |
| 33279 | 2022 | 2023-03-26 | 609286 | 2022-001 | Significant Deficiency | - | N |
| 33279 | 2022 | 2023-03-26 | 609285 | 2022-001 | Significant Deficiency | - | N |
| 33279 | 2022 | 2023-03-26 | 32847 | 2022-002 | Significant Deficiency | Yes | L |
| 33279 | 2022 | 2023-03-26 | 32846 | 2022-002 | Significant Deficiency | Yes | L |
| 33279 | 2022 | 2023-03-26 | 32845 | 2022-002 | Significant Deficiency | Yes | L |
| 33279 | 2022 | 2023-03-26 | 32844 | 2022-001 | Significant Deficiency | - | N |
| 33279 | 2022 | 2023-03-26 | 32843 | 2022-001 | Significant Deficiency | - | N |